SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001432354-24-000009
Filing Date
2024-02-14
Accepted
2024-02-14 15:13:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 ANNUAL SC 13G - POTX/MYMD PHARMACEUTICALS annualsc13g-potxmymdpharma.htm SC 13G 53881
  Complete submission text file 0001432354-24-000009.txt   55666
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Subject) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88005 | Film No.: 24636665
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 605 THIRD AVENUE 43RD FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 43RD FLOOR NEW YORK NY 10158 (212) 644-6110
Global X Management CO LLC (Filed by) CIK: 0001432354 (see all company filings)

IRS No.: 223978238 | State of Incorp.: DE
Type: SC 13G